62 0

Comparison of effect that ticagrelor and triple antiplatelet therapy affect platelet reactivity

Title
Comparison of effect that ticagrelor and triple antiplatelet therapy affect platelet reactivity
Author
신진호
Keywords
Cardiac; Cardiovascular Systems; Cardiology
Issue Date
2013-10
Publisher
ELSEVIER SCIENCE INC, 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
Citation
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY,2013,62(18), p B49-B49
Abstract
High platelet reactivity (HPR) is associated with poor prognosis in coronary artery disease. Recently PLATO subgroup analysis showed that ticagrelor is better clinical outcome than the clopidogrel, which was related with low HPR. Also many studies reported that adjunctive cilostazol to dual antiplatelet therapy (DAPT) (so called triple antiplatelet therapy; TAT) is better clinical outcome than DAPT, which was associated with a greater antiplatelet effect at 30 days. Thus, this study was designed to compare the effect of ticagrelor and TAT on platelet reactivity with PRU and ARU values.
URI
https://www.sciencedirect.com/science/article/pii/S0735109713042861?via%3Dihubhttp://hdl.handle.net/20.500.11754/42765
ISSN
0735-1097
DOI
10.1016/j.jacc.2013.08.886
Appears in Collections:
COLLEGE OF MEDICINE[S](의과대학) > MEDICINE(의학과) > Articles
Files in This Item:
There are no files associated with this item.
Export
RIS (EndNote)
XLS (Excel)
XML


qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

BROWSE